275 related articles for article (PubMed ID: 16651432)
1. Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells.
Bertram J; Peacock JW; Tan C; Mui AL; Chung SW; Gleave ME; Dedhar S; Cox ME; Ong CJ
Cancer Res; 2006 May; 66(9):4781-8. PubMed ID: 16651432
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
Lu B; Wang L; Stehlik C; Medan D; Huang C; Hu S; Chen F; Shi X; Rojanasakul Y
J Immunol; 2006 Jun; 176(11):6785-93. PubMed ID: 16709838
[TBL] [Abstract][Full Text] [Related]
3. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
4. Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death.
Zhu L; Derijard B; Chakrabandhu K; Wang BS; Chen HZ; Hueber AO
Cancer Lett; 2014 Nov; 354(2):355-64. PubMed ID: 25199763
[TBL] [Abstract][Full Text] [Related]
5. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
[TBL] [Abstract][Full Text] [Related]
6. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
7. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
8. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
9. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
10. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.
Chakraborty M; Qiu SG; Vasudevan KM; Rangnekar VM
Cancer Res; 2001 Oct; 61(19):7255-63. PubMed ID: 11585763
[TBL] [Abstract][Full Text] [Related]
11. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.
Osaki M; Kase S; Adachi K; Takeda A; Hashimoto K; Ito H
J Cancer Res Clin Oncol; 2004 Jan; 130(1):8-14. PubMed ID: 14605879
[TBL] [Abstract][Full Text] [Related]
13. The Fas-FasL death receptor and PI3K pathways independently regulate monocyte homeostasis.
Perlman H; Pagliari LJ; Nguyen N; Bradley K; Liu H; Pope RM
Eur J Immunol; 2001 Aug; 31(8):2421-30. PubMed ID: 11500826
[TBL] [Abstract][Full Text] [Related]
14. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival.
Goswami A; Burikhanov R; de Thonel A; Fujita N; Goswami M; Zhao Y; Eriksson JE; Tsuruo T; Rangnekar VM
Mol Cell; 2005 Oct; 20(1):33-44. PubMed ID: 16209943
[TBL] [Abstract][Full Text] [Related]
15. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3.
Shi M; Zhou X; Zhang Z; Wang M; Chen G; Han K; Cao B; Liu Z; Mao X
Toxicol Lett; 2014 Aug; 228(3):133-9. PubMed ID: 24831963
[TBL] [Abstract][Full Text] [Related]
16. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.
Uriarte SM; Joshi-Barve S; Song Z; Sahoo R; Gobejishvili L; Jala VR; Haribabu B; McClain C; Barve S
Cell Death Differ; 2005 Mar; 12(3):233-42. PubMed ID: 15665818
[TBL] [Abstract][Full Text] [Related]
17. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.
Lee TJ; Sartor O; Luftig RB; Koochekpour S
Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330
[TBL] [Abstract][Full Text] [Related]
18. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway.
Poh TW; Pervaiz S
Cancer Res; 2005 Jul; 65(14):6264-74. PubMed ID: 16024628
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
